Barclays Forecasts Strong Price Appreciation for Mettler-Toledo International (NYSE:MTD) Stock

Mettler-Toledo International (NYSE:MTD) had its price target lifted by stock analysts at Barclays from $1,350.00 to $1,600.00 in a report released on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical instruments supplier’s stock. Barclays‘s price target would suggest a potential upside of 10.63% from the stock’s current price.

Several other research firms have also commented on MTD. Bank of America upped their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research report on Monday, September 22nd. Wells Fargo & Company increased their price target on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a report on Monday. JPMorgan Chase & Co. raised their price target on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research report on Thursday, October 9th. Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Finally, Citigroup increased their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research note on Thursday, August 21st. Five investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, Mettler-Toledo International currently has a consensus rating of “Hold” and a consensus price target of $1,406.50.

Mettler-Toledo International Stock Performance

NYSE:MTD opened at $1,446.25 on Monday. The firm’s fifty day moving average is $1,326.50 and its two-hundred day moving average is $1,243.39. The firm has a market cap of $29.79 billion, a price-to-earnings ratio of 36.62, a PEG ratio of 4.19 and a beta of 1.41. Mettler-Toledo International has a one year low of $946.69 and a one year high of $1,462.09.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. During the same quarter in the previous year, the firm posted $10.21 EPS. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. As a group, equities research analysts predict that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the sale, the chief financial officer owned 5,095 shares of the company’s stock, valued at $6,750,875. The trade was a 5.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Gerry Keller sold 165 shares of the business’s stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the transaction, the insider owned 94 shares in the company, valued at $123,012.16. The trade was a 63.71% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Institutional investors have recently made changes to their positions in the company. Russell Investments Group Ltd. boosted its stake in shares of Mettler-Toledo International by 29.0% in the 1st quarter. Russell Investments Group Ltd. now owns 116,502 shares of the medical instruments supplier’s stock valued at $137,548,000 after buying an additional 26,171 shares during the period. Legato Capital Management LLC raised its holdings in Mettler-Toledo International by 107.7% in the first quarter. Legato Capital Management LLC now owns 2,050 shares of the medical instruments supplier’s stock valued at $2,421,000 after acquiring an additional 1,063 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its stake in Mettler-Toledo International by 46.7% in the first quarter. Tokio Marine Asset Management Co. Ltd. now owns 7,829 shares of the medical instruments supplier’s stock worth $9,245,000 after acquiring an additional 2,493 shares during the last quarter. Sound Income Strategies LLC grew its holdings in Mettler-Toledo International by 477.8% during the 2nd quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after acquiring an additional 43 shares in the last quarter. Finally, Envestnet Asset Management Inc. grew its holdings in Mettler-Toledo International by 2.5% during the 1st quarter. Envestnet Asset Management Inc. now owns 15,823 shares of the medical instruments supplier’s stock worth $18,686,000 after acquiring an additional 393 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.